Babar Ghias

Babar Ghias

Chief Financial OfficeratBiocryst Pharmaceuticals· In the 2025 proxy

Pay in FY2025Biocryst Pharmaceuticals stock +3.7% the same year

Babar Ghias was paid $6.7M in FY2025 (Dec). Biocryst Pharmaceuticals stock rose 3.7% that year.

Pay$100 in the stock at the end of FY24 → $104
Pay is from the Summary Compensation Table of each Biocryst Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Biocryst PharmaceuticalsPublic company · 1 yr
    • Chief Financial Officer2025 – Present · 1 yrStock in role +9%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?